259 related articles for article (PubMed ID: 22078185)
1. Comparison of contraceptive method chosen by women with and without a recent history of induced abortion.
Madden T; Secura GM; Allsworth JE; Peipert JF
Contraception; 2011 Dec; 84(6):571-7. PubMed ID: 22078185
[TBL] [Abstract][Full Text] [Related]
2. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
3. The influence of trust in health care systems on postabortion contraceptive choice.
Stacey RE; Dempsey A
Contraception; 2015 Nov; 92(5):458-62. PubMed ID: 26197264
[TBL] [Abstract][Full Text] [Related]
4. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
Rose SB; Garrett SM; Stanley J
Contraception; 2015 Jul; 92(1):17-25. PubMed ID: 25818594
[TBL] [Abstract][Full Text] [Related]
5. Trends and determinants of postabortion contraception use in a Canadian retrospective cohort.
Burk JC; Norman WV
Contraception; 2019 Aug; 100(2):96-100. PubMed ID: 31100218
[TBL] [Abstract][Full Text] [Related]
6. Postabortion Initiation of Long-Acting Reversible Contraception by Adolescent and Nulliparous Women in New Zealand.
Rose SB; Garrett SM
J Adolesc Health; 2016 Feb; 58(2):160-6. PubMed ID: 26603946
[TBL] [Abstract][Full Text] [Related]
7. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive discontinuation and pregnancy postabortion in Nepal: a longitudinal cohort study.
Puri M; Henderson JT; Harper CC; Blum M; Joshi D; Rocca CH
Contraception; 2015 Apr; 91(4):301-7. PubMed ID: 25553872
[TBL] [Abstract][Full Text] [Related]
9. Regional variation in postabortion initiation of long-acting reversible contraception in New Zealand.
Rose SB; Garrett SM
Aust N Z J Obstet Gynaecol; 2016 Jun; 56(3):315-22. PubMed ID: 27060549
[TBL] [Abstract][Full Text] [Related]
10. Effect of previous induced abortions on postabortion contraception selection.
Keene M; Roston A; Keith L; Patel A
Contraception; 2015 May; 91(5):398-402. PubMed ID: 25637863
[TBL] [Abstract][Full Text] [Related]
11. Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
Krashin JW; Stuart GS; Garrett J; Spector H; Bryant AG; Charm S; Morse JE
Obstet Gynecol; 2017 Jul; 130(1):109-117. PubMed ID: 28594755
[TBL] [Abstract][Full Text] [Related]
12. Impact of long-acting reversible contraception on return for repeat abortion.
Rose SB; Lawton BA
Am J Obstet Gynecol; 2012 Jan; 206(1):37.e1-6. PubMed ID: 21944222
[TBL] [Abstract][Full Text] [Related]
13. Attitudes toward long-acting reversible contraception among young women seeking abortion.
Rose SB; Cooper AJ; Baker NK; Lawton B
J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
[TBL] [Abstract][Full Text] [Related]
14. Contraception after medication abortion in the United States: results from a cluster randomized trial.
Rocca CH; Goodman S; Grossman D; Cadwallader K; Thompson KMJ; Talmont E; Speidel JJ; Harper CC
Am J Obstet Gynecol; 2018 Jan; 218(1):107.e1-107.e8. PubMed ID: 28986072
[TBL] [Abstract][Full Text] [Related]
15. Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.
Goyal V; Canfield C; Aiken ARA; Dermish A; Potter JE
Obstet Gynecol; 2017 Apr; 129(4):655-662. PubMed ID: 28277358
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and the choice of long-acting reversible contraception following medical abortion: effect on subsequent induced abortion and unwanted pregnancy.
Korjamo R; Heikinheimo O; Mentula M
Eur J Contracept Reprod Health Care; 2018 Apr; 23(2):89-96. PubMed ID: 29537321
[TBL] [Abstract][Full Text] [Related]
17. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
18. Funding policies and postabortion long-acting reversible contraception: results from a cluster randomized trial.
Rocca CH; Thompson KM; Goodman S; Westhoff CL; Harper CC
Am J Obstet Gynecol; 2016 Jun; 214(6):716.e1-8. PubMed ID: 26692178
[TBL] [Abstract][Full Text] [Related]
19. Intimate Partner Violence and Effectiveness Level of Contraceptive Selection Post-Abortion.
Drew LB; Mittal M; Thoma ME; Harper CC; Steinberg JR
J Womens Health (Larchmt); 2020 Aug; 29(8):1142-1149. PubMed ID: 31721639
[No Abstract] [Full Text] [Related]
20. Use of Contraception and Attitudes towards Contraceptive Use in Swedish Women--A Nationwide Survey.
Kopp Kallner H; Thunell L; Brynhildsen J; Lindeberg M; Gemzell Danielsson K
PLoS One; 2015; 10(5):e0125990. PubMed ID: 25992901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
